Physician profile
Luis Barrera
NPI 1174277198
$1,235.30
in general payments reported to CMS, 2019-2025
23 companies · $600 in 2025
The $600 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $479 · 2023: $31.72 · 2024: $125 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.80 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $175.30 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $156.36 | 2025 | Eylea Hd |
| Astellas Pharma US INC | $154.92 | 2022-2024 | Veozah |
| Ani Pharmaceuticals, INC. | $115.39 | 2025 | Purified Cortrophin Gel |
| Novo Nordisk INC | $63.51 | 2022 | |
| Lilly USA, LLC | $61.98 | 2022 | |
| Abbott Laboratories | $57.37 | 2023-2025 | Freestyle Libre, Eterna |
| Ironwood Pharmaceuticals, INC | $52.66 | 2022 | |
| Glaxosmithkline, LLC. | $47.91 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.77 | 2022 | |
| Mallinckrodt Hospital Products INC. | $40.46 | 2025 | Acthar |
| Tarsus Pharmaceuticals, INC. | $39.57 | 2025 | Xdemvy |
| Astrazeneca Pharmaceuticals Lp | $30.97 | 2022 | |
| Genentech USA, INC. | $26.56 | 2025 | Susvimo |
| Amgen INC. | $25.50 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $24.58 | 2025 | Iyuzeh |
| Amarin Pharma, INC. | $21.87 | 2022 | |
| Sanofi-Aventis U.S. LLC | $19.03 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.75 | 2022 | |
| Rxsight INC | $17.18 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Merck Sharp & Dohme LLC | $14.56 | 2022 | |
| Pfizer INC. | $14.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Barrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.